Director Vijayrao Narsing Krishna of Aehr Test Systems filed a Form 4 on October 29, 2026, reporting the acquisition of 2,169 shares of common stock through a restricted stock unit award on October 28, 2026, at a price of $0.
Key Highlights
- Reporting person: Vijayrao Narsing Krishna, identified as a Director of Aehr Test Systems (NASDAQ:AEHR).
- Transaction: 2,169 shares of common stock acquired (transaction code A) on October 28, 2026, at a price of $0.
- Vesting schedule: One-sixteenth (1/16) of the total shares subject to the restricted stock unit award vest at the end of each three full calendar months following the date of the action, provided the recipient remains employed.
- Post-transaction holdings: 3,169 shares of common stock beneficially owned following the reported transaction, held directly.
- Unvested units included: The 3,169 total reported includes shares subject to unvested restricted stock units, according to the filing.
- Filed by: Chris Siu, Attorney-in-Fact, on behalf of the reporting person, signed October 29, 2026.
Aehr Test Systems Director Krishna Receives RSU Award in October 2026
According to the Form 4 filed with the U.S. Securities and Exchange Commission, Vijayrao Narsing Krishna, a director of Aehr Test Systems, acquired 2,169 shares of common stock on October 28, 2026, under a restricted stock unit award at a price of $0. The filing lists the transaction code as "A," indicating an acquisition. The shares are held directly by the reporting person.
The filing discloses that the vesting schedule for the award calls for one-sixteenth (1/16) of the total shares subject to the restricted stock unit award to vest at the end of each three full calendar months following the date of the action, "provided that such recipient is still employed by the corporation on such dates." Following this transaction, the total amount of common stock beneficially owned by Krishna is reported as 3,169 shares, a figure the filing notes includes shares subject to unvested restricted stock units.
The form was filed on October 29, 2026, and signed by Chris Siu as Attorney-in-Fact for the reporting person. No derivative securities transactions were reported in Table II of the filing. The filing does not indicate that it is an amendment to a previously filed form.
What Was Disclosed
Director Vijayrao Narsing Krishna reported acquiring 2,169 shares of Aehr Test Systems common stock via a restricted stock unit award at $0 on October 28, 2026, bringing his total beneficial ownership to 3,169 shares, including unvested units.



Please wait processing your request...